LU92401I2
Topical gel delivery systems for treating skin disorders
Abstract
This record has no abstract on file.
Term
7.5 yearsto projected expiry
Projected expiry 18 March 2034, counted from filing; an application has no term until it is granted.
- Priority
- Filed
- Published
- Today
- Projected expiry
50 members in 25 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 63250800 | United States of America | A | |
| 63250800 | United States of America | A | |
| US20000632508 | – | – | – |
Members50
| Document | Office | Kind | |
|---|---|---|---|
| CA2417646A1 | Canada | A1 | |
| WO0211683A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU7900201A | Australia | A | |
| AU7900201A | Australia | A | |
| US6387383B1 | United States of America | B1 | |
| US2002176891A1 | United States of America | A1 | |
| US6517847B2 | United States of America | B2 | |
| EP1304992A1 | European Patent Office (EPO) | A1 | |
| BR0113247A | Brazil | A | |
| KR20030057526A | Republic of Korea | A | |
| AR030093A1 | Argentina | A1 | |
| CN1460013A | China | A | |
| JP2004505900A | Japan | A | |
| ZA200301037B | South Africa | B | |
| PL360589A1 | Poland | A1 | |
| MXPA03001006A | Mexico | A | |
| RU2251410C2 | Russian Federation | C2 | |
| AU2001279002B2 | Australia | B2 | |
| EP1304992A4 | European Patent Office (EPO) | A4 | |
| KR20080036246A | Republic of Korea | A | |
| KR100840169B1 | Republic of Korea | B1 | |
| CN101305982A | China | A | |
| EP1304992B1 | European Patent Office (EPO) | B1 | |
| EP2052714A1 | European Patent Office (EPO) | A1 | |
| AT429922T | Austria | T | |
| ATE429922T1 | Austria | T1 | |
| DE60138549D1 | Germany | D1 | |
| PT1304992E | Portugal | E | |
| DK1304992T3 | Denmark | T3 | |
| HK1125847A | Hong Kong, China | A | |
| HK1125847A1 | Hong Kong, China | A1 | |
| ES2326955T3 | Spain | T3 | |
| SI1304992T1 | Slovenia | T1 | |
| CA2417646C | Canada | C | |
| CN101305982B | China | B | |
| CN1460013B | China | B | |
| JP4988129B2 | Japan | B2 | |
| PL213237B1 | Poland | B1 | |
| EP2052714B1 | European Patent Office (EPO) | B1 | |
| DK2052714T3 | Denmark | T3 | |
| PT2052714E | Portugal | E | |
| SI2052714T1 | Slovenia | T1 | |
| ES2437321T3 | Spain | T3 | |
| LU92401I2This record | Luxembourg | I2 | |
| CY1109189T1 | Cyprus | T1 | |
| CY2014005I1 | Cyprus | I1 | |
| FR14C0053I1 | France | I1 | |
| CY2014005I2 | Cyprus | I2 | |
| CY1114646T1 | Cyprus | T1 | |
| BE2013C060I2 | Belgium | I2 |
Numbers
- Publication, DOCDB
- 92401
- Publication, EPODOC
- LU92401I
- Application
- 92401
- Application, DOCDB
- 92401
- Application, EPODOC
- LU20140092401C
Titles2
- English
- Clindamycin (as clindamycin phosphate) and tretinoin
- French
- Clindamycine (en tant que phosphate de clindamycine) et tretinoine
Classification
- CPC, 22
- A61K31/7036
- A61K47/00
- A61K9/0014
- A61K31/192
- A61K31/196
- A61K31/57
- A61K31/573
- A61K31/58
- A61K31/7034
- A61K31/7056
- A61K45/06
- A61K47/02
- A61K47/10
- A61K47/18
- A61K47/32
- A61P17/00
- A61P17/02
- A61P17/04
- A61P17/10
- A61K31/70
- A61K31/20
- A61P29/00
- IPC, 21
- A61K9 06
- A61K9 107
- A61K31 192
- A61K31 196
- A61K31 20
- A61K31 57
- A61K31 58
- A61K31 7056
- A61K45 06
- A61K47 02
- A61K47 10
- A61K47 14
- A61K47 18
- A61K47 22
- A61K47 32
- A61K47 34
- A61P17 00
- A61P17 02
- A61P17 04
- A61P17 10
- A61P29 00